Crossmark

Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?

Crossref DOI link: https://doi.org/10.1186/2193-1801-3-282

Published Online: 2014-06-04

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kemp, Anna

Preen, David B

Saunders, Christobel

Boyle, Frances

Bulsara, Max

Malacova, Eva

Roughead, Elizabeth E
License Information

Text and Data Mining valid from 2014-06-04
More Information

Article History

Received: 22 May 2014

Accepted: 22 May 2014

First Online: 4 June 2014